Utah Approves Nolla Health Pilot for AI-Driven Acne Prescriptions
Utah has permitted startup Nolla Health to launch a pilot project allowing an AI agent to issue prescription refills and initial acne treatments with minimal human oversight.
Utah has become the first state in the U.S. to authorize an artificial intelligence startup to automate the approval of prescriptions with minimal human physician oversight. Nolla Health announced that it has received state approval to launch a pilot project enabling acne sufferers to interact with an AI agent, upload facial photos, and receive prescriptions without directly speaking to a doctor.
Founder Luis Wenus described the development on social media, noting that the system establishes an end-to-end approach where the AI selects specific medicines from a physician-approved shortlist of topical treatments. The service is accessed through the Nolla Derm iOS app. Users complete an intake process, describe their condition, and submit facial scans. The AI then determines a treatment plan, which can be sent to a home address or a local pharmacy. Daily skin scans track progress, and treatment plans are updated monthly.
Structure of the Regulatory Pilot
The pilot program is proceeding under the supervision of the Utah Office of Artificial Intelligence Policy, the Utah Division of Professional Licensing, the Utah Medical Association, and the American Academy of Dermatology. It is part of Utah's AI Learning Lab sandbox program, which offers firms regulatory relief to test innovations under supervised conditions. State officials noted that participation in the sandbox does not signify an endorsement or certification of the product.
Under the rules of the agreement, the AI is restricted to prescribing topical acne creams and is barred from prescribing isotretinoin or oral medications. The pilot is divided into three distinct phases:
- Phase 1: Two physicians must review and approve every AI-generated prescription before it is sent out, covering the first 100 patients.
- Phase 2: The AI will issue prescriptions directly without prior human approval, with physicians conducting after-the-fact reviews for a group of 500 patients.
- Phase 3: Human physicians will review a minimum of 10% of all automated prescriptions on a monthly basis.
Requests falling outside strict operational limits are forwarded directly to licensed human physicians.
Expanding Beyond Dermatology
Nolla Health Chief Medical Adviser Zaid Fadul noted that acne treatment serves as an initial proof-of-concept. If the pilot succeeds, the startup plans to explore automated prescription services for other well-understood common conditions that are easily assessed remotely and treated with medications possessing strong safety profiles. Fadul mentioned conditions such as the flu and uncomplicated urinary tract infections as potential candidates, provided clear guardrails are maintained. Developers interested in building and testing similar healthcare or administrative applications can try top AI models cheaply through one API at https://apixoai.online.
Looking further ahead, Fadul expects AI to handle routine healthcare checks, diagnostics, and prescription refills within a decade. However, he emphasized that AI will remain unsuited for serious medical conditions, life-changing diagnoses, and high-risk medications such as opioids, stimulants, and benzodiazepines, which carry a risk of user manipulation and require robust evidence and safeguards before autonomous prescribing can be considered.
Source: Utah gives startup Nolla Health permission to start issuing AI automated prescriptions for acne treatments — SiliconANGLE AI. Written by the Apixo team from that report.
One key for Claude, GPT, GLM, DeepSeek and more. Pay per token with crypto.
Get your API key
